Kiniksa Pharmaceuticals International, plc (KNSA)

KNSA Revenue by Segment

Period Ending	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021
Product	677.56M	597.97M	529.33M	475.93M	417.03M	365.71M	318.30M	269.40M
Product Growth	62.47%	63.51%	66.30%	76.66%	78.85%	81.14%	86.67%	88.40%
License and Collaboration	-	-	-	-	-	-	20.63M	32.37M
License and Collaboration Growth	-	-	-	-	-	-	-81.30%	-65.32%

Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.